Published in J Toxicol on June 08, 2016
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Dopamine receptors: from structure to function. Physiol Rev (1998) 8.90
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science (1990) 8.07
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (1996) 7.26
Cancer risks from arsenic in drinking water. Environ Health Perspect (1992) 6.98
The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev (2011) 5.25
Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol (1998) 4.42
Exposure to arsenic and lead and neuropsychological development in Mexican children. Environ Res (2001) 3.33
Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature (1995) 2.37
The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology (2003) 2.29
Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. Environ Health Perspect (1998) 1.99
Survival of reproductive behaviors in estrogen receptor beta gene-deficient (betaERKO) male and female mice. Proc Natl Acad Sci U S A (1999) 1.99
Chronic arsenic poisoning in the north of Mexico. Hum Toxicol (1983) 1.88
Arsenic exposure and cognitive performance in Mexican schoolchildren. Environ Health Perspect (2007) 1.78
Influence of arsenate and arsenite on signal transduction pathways: an update. Arch Toxicol (2010) 1.76
Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacology (Berl) (2002) 1.73
Neuroanatomical differences between mouse strains as shown by high-resolution 3D MRI. Neuroimage (2005) 1.50
Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu Rev Pharmacol Toxicol (2007) 1.44
Critical windows of exposure for arsenic-associated impairment of cognitive function in pre-school girls and boys: a population-based cohort study. Int J Epidemiol (2011) 1.40
The effects of arsenic exposure on the nervous system. Toxicol Lett (2003) 1.36
Arsenic and diabetes and hypertension in human populations: a review. Toxicol Appl Pharmacol (2007) 1.31
Long-term consequences of arsenic poisoning during infancy due to contaminated milk powder. Environ Health (2006) 1.26
Intruder-evoked aggression in isolated and nonisolated mice: effects of psychomotor stimulants and L-dopa. Psychopharmacology (Berl) (1978) 1.20
Neuropathy in arsenic toxicity from groundwater arsenic contamination in West Bengal, India. J Environ Sci Health A Tox Hazard Subst Environ Eng (2003) 1.18
Acute arsenic intoxication from environmental arsenic exposure. Arch Environ Health (1990) 1.16
Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy. J Pharmacol Exp Ther (1994) 1.10
Effects of lead-arsenic combined exposure on central monoaminergic systems. Neurotoxicol Teratol (1997) 1.09
Toxic heavy metals: materials cycle optimization. Proc Natl Acad Sci U S A (1992) 1.05
Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Res (1989) 1.04
The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice. Eur J Pharmacol (1986) 1.01
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur J Pharmacol (1994) 1.00
The effects of sodium arsenite exposure on behavioral parameters in the rat. Brain Res Bull (2001) 1.00
Effects of arsenic exposure from drinking water on spatial memory, ultra-structures and NMDAR gene expression of hippocampus in rats. Toxicol Lett (2008) 0.99
Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environ Res (1981) 0.98
Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: reversal by increasing synaptic dopamine. J Pharmacol Exp Ther (1995) 0.96
The organization of intraspecific agonistic behaviour in the rat. Prog Neurobiol (1980) 0.95
Magnitude of arsenic toxicity in tube-well drinking water in Bangladesh and its adverse effects on human health including cancer: evidence from a review of the literature. Asian Pac J Cancer Prev (2003) 0.94
Chronic low-level arsenic exposure causes gender-specific alterations in locomotor activity, dopaminergic systems, and thioredoxin expression in mice. Toxicol Appl Pharmacol (2008) 0.91
Brain regional responses in antioxidant system to alpha-lipoic acid in arsenic intoxicated rat. Toxicology (2005) 0.91
Comparison of ethanol preference and neurochemical measures of mesolimbic dopamine and adenosine systems across different strains of mice. Alcohol Clin Exp Res (2006) 0.90
Arsenic and cancer. Can Med Assoc J (1975) 0.89
Chronic exposure to low levels of inorganic arsenic causes alterations in locomotor activity and in the expression of dopaminergic and antioxidant systems in the albino rat. Neurotoxicol Teratol (2010) 0.88
Influence of noradrenaline denervation on MPTP-induced deficits in mice. J Neural Transm (Vienna) (2005) 0.88
Glutathione reductase inhibition and methylated arsenic distribution in Cd1 mice brain and liver. Toxicol Sci (2004) 0.87
Regional alterations in the levels of brain biogenic amines, glutamate, GABA, and GAD activity due to chronic consumption of inorganic arsenic in developing and adult rats. Bull Environ Contam Toxicol (1993) 0.87
The effect of arsenic trioxide on brain monoamine metabolism and locomotor activity of mice. Toxicol Lett (1990) 0.86
Arsenic species, AS3MT amount, and AS3MT gene expression in different brain regions of mouse exposed to arsenite. Environ Res (2010) 0.86
Arsenic-induced changes in certain neurotransmitter levels and their recoveries following chelation in rat whole brain. Toxicol Lett (1997) 0.83
Animal species difference in the uptake of dimethylarsinous acid (DMA(III)) by red blood cells. Chem Res Toxicol (2001) 0.83
A study on behavioral, neurotoxicological, and immunotoxicological effects of subchronic arsenic treatment in rats. J Toxicol Environ Health A (2002) 0.83
Altered performance characteristics in cognitive tasks: comparison of the albino ICR and CD1 mouse strains. Behav Brain Res (2002) 0.82
Haloperiodol-induced microcatalepsy differs in CD-1, BALB/c, and C57BL/6 mice. Exp Clin Psychopharmacol (2001) 0.81
Early life arsenic exposure and brain dopaminergic alterations in rats. Int J Dev Neurosci (2014) 0.81
Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study. Neuroscience (1991) 0.80
Postnatal arsenic exposure and attention impairment in school children. Cortex (2015) 0.80
Arsenic exposure in drinking water alters the dopamine system in the brains of C57BL/6 mice. Biol Trace Elem Res (2014) 0.79
Fluoride and arsenic exposure impairs learning and memory and decreases mGluR5 expression in the hippocampus and cortex in rats. PLoS One (2014) 0.79
Effect of one hyperbaric oxygen-induced convulsion on cortical polyamine content in two strains of mice. Neurosci Lett (1993) 0.78
Neurobehavioral effects of arsenic exposure among secondary school children in the Kandal Province, Cambodia. Environ Res (2015) 0.77
The interaction of phenyldichloroarsine with erythrocytes. J Biochem Toxicol (1989) 0.77
Effects of inorganic arsenic exposure on glucose transporters and insulin receptor in the hippocampus of C57BL/6 male mice. Neurotoxicol Teratol (2016) 0.76
Amphetamine-induced on- and off-wall rearing in adult laboratory rats. Pharmacol Biochem Behav (1987) 0.76
Regional brain bioamine levels under hyperbaric oxygen in two unequally susceptible strains of mice. Aviat Space Environ Med (2000) 0.76